Kimberly A Smith

发表

Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events.

N. Weissman, G. Mintz, K. Kent, 2008, The Journal of invasive cardiology.

Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Impact of in-stent restenosis on death and myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Comparison between sirolimus‐ and paclitaxel‐eluting stents in complex patient and lesions subsets

K. Kent, A. Pichard, R. Torguson, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2006, Circulation.

Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease

K. Kent, A. Pichard, L. Satler, 2007, Circulation.

Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment.

N. Weissman, G. Mintz, K. Kent, 2007, The American journal of cardiology.

Relation of drug-eluting stent strut distribution to stent thrombosis in coronary arteries.

N. Weissman, G. Mintz, K. Kent, 2009, The American journal of cardiology.

Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings.

N. Weissman, G. Mintz, K. Kent, 2008, The American journal of cardiology.

Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.

N. Weissman, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2008, Cardiovascular revascularization medicine : including molecular interventions.